Demonstrating Easily Accessible Parameters for Patient Selection in Major Depression Trials Utilizing Autonomic Markers for Treatment With the 11beta-HSD2 Inhibitors Glycyrrhizin & Enoxolone
Time: 11:30 am
day: Track 2 AM Day 1
Details:
- Demonstrate utility of patient selection based on biomarkers of autonomic regulation: blood pressure, heart rate, metabolism and endocrine markers
- Demonstrating predictive value of autonomic markers for symptom improvement and treatment differentiation in major depression
- Discussing an example based on the effect of the 11beta hydoxysteroid-dehydrogenase type 2 (11betaHSD2) inhibitors glycyrrhizin and enoxolone.
